| Literature DB >> 30306364 |
Lara Hessels1, Annemieke Oude Lansink-Hartgring2, Miriam Zeillemaker-Hoekstra2,3, Maarten W Nijsten2.
Abstract
BACKGROUND: Nonosmotic sodium storage has been reported in animals, healthy individuals and patients with hypertension, hyperaldosteronism and end-stage kidney disease. Sodium storage has not been studied in ICU patients, who frequently receive large amounts of sodium chloride-containing fluids. The objective of our study was to estimate sodium that cannot be accounted for by balance studies in critically ill patients. Chloride was also studied. We used multiple scenarios and assumptions for estimating sodium and chloride balances.Entities:
Keywords: Chloride; Extracellular volume; Intensive care unit; Intracellular volume; Sodium
Year: 2018 PMID: 30306364 PMCID: PMC6179979 DOI: 10.1186/s13613-018-0442-2
Source DB: PubMed Journal: Ann Intensive Care ISSN: 2110-5820 Impact factor: 6.925
Patients characteristics
| Age (years) | 66 (13) |
| Sex, male | 28 (74%) |
| Reason of admission | |
| Cardiothoracic surgery | 31 (82%) |
| Trauma | 1 (3%) |
| Vascular surgery | 1 (3%) |
|
| 5 (13%) |
| LOS ICU (days) | 7.4 (4.8–13.7) |
| Patients on diuretics | 25 (66%) |
| APACHE-IV | 60 (44-71) |
| Hospital mortality | 4 (11%) |
| AKI | 11 (29%) |
| Stage 1 | 6 (55%) |
| Stage 2 | 3 (27%) |
| Stage 3 | 2 (18%) |
Data are depicted as mean (SD), n (%) or median (interquartile range) as appropriate
APACHE Acute Physiology and Chronic Health Evaluation
Cumulative data on fluid and electrolyte administration
| Day 1 | Day 2 | Day 3 | Day 4 | ||
|---|---|---|---|---|---|
|
| |||||
| Fluid (L) | 3.6 ± 0.4 | 7.9 ± 0.5 | 11.0 ± 0.5 | 13.6 ± 0.6 | |
| Sodium (mmol) | 460 ± 52 | 935 ± 67 | 1235 ± 72 | 1441 ± 75 | |
| Chloridea (mmol) | 420 ± 53 | 872 ± 68 | 1162 ± 79 | 1377 ± 76 | |
|
| |||||
| Fluid (L) | 1.6 ± 0.1 | 3.9 ± 0.2 | 6.5 ± 0.3 | 8.9 ± 0.3 | |
| Sodium (mmol) | 139 ± 14 | 293 ± 23 | 472 ± 30 | 626 ± 35 | |
| Chloridea (mmol) | 117 ± 17 | 255 ± 28 | 418 ± 43 | 574 ± 47 | |
|
| |||||
| Fluid (L) | 1.9 ± 0.3 | 3.7 ± 0.5 | 4.0 ± 0.5 | 3.9 ± 0.6 | |
| Sodium (mmol) | 321 ± 47 | 642 ± 62 | 769 ± 72 | 822 ± 76 | |
| Chloridea (mmol) | 274 ± 51 | 498 ± 66 | 535 ± 82 | 556 ± 82 | |
| Plasma sodium (mmol/L) | 137.1 ± 0.5 | 136.6 ± 0.5 | 136.2 ± 0.6 | 136.9 ± 0.5 | 0.741 |
| Plasma chloridea (mmol/L) | 109.8 ± 0.9 | 109.3 ± 0.8 | 108.2 ± 0.9 | 108.0 ± 0.9 | 0.107 |
Data are depicted as mean ± SE
* Difference between day 1 and day 4
aChloride data were available for 27, 27, 24 and 28 patients, respectively, on day 1 to day 4
Fig. 1Time course of estimated cumulative MES and MEC for the first four ICU days. Values are depicted as mean ± SE. The first values reflect levels at ICU admission, when storage was assumed defined as zero. The values at the subsequent time points reflect levels at the end (i.e., midnight) of each ICU day. As can be seen under normal and stable circulating electrolyte levels (Table 2), a significant amount of sodium (MES) and chloride (MEC) ‘disappears’ from the balances over the first four ICU days
Fig. 2Scenarios for both estimated cumulative MES and MEC. Values are depicted as mean ± 95% CI. The 95% CI is represented by the dotted lines. The first values reflect levels at ICU admission, when storage was assumed to be zero. In all scenarios, there were considerable MES and MEC after 4 days of ICU admission. a With stable sodium levels, MES is mostly influenced by altering the insensible perspiration. b MEC showed a similar pattern as MES, but was slightly more affected by the changes in the extracellular compartment than MES
Fig. 3Estimated cumulative MES and MEC according to different scenarios. Values are depicted as means. The calculated MES (blue), MEC (red) and their difference (light gray) on ICU day 4 according to the scenarios with different assumptions on perspiration and the size of the extracellular volume